QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
QQQ   303.46 (+1.28%)
AAPL   122.72 (+3.08%)
MSFT   216.21 (+1.00%)
FB   286.55 (+3.46%)
GOOGL   1,795.36 (+2.33%)
AMZN   3,220.08 (+1.64%)
TSLA   584.76 (+3.02%)
NVDA   535.60 (-0.09%)
BABA   264.01 (+0.25%)
CGC   26.65 (-7.47%)
GE   10.15 (-0.29%)
MU   67.08 (+4.67%)
AMD   92.63 (-0.03%)
T   28.87 (+0.42%)
NIO   45.36 (-10.23%)
F   9.24 (+1.76%)
ACB   9.75 (-16.52%)
NFLX   504.58 (+2.83%)
BA   213.01 (+1.09%)
GILD   61.12 (+0.74%)
DIS   149.44 (+0.97%)
Log in
NYSEAMERICAN:REED

Reed's Competitors

$0.69
+0.04 (+6.15 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.64
Now: $0.69
$0.71
50-Day Range N/A
52-Week Range
$0.36
Now: $0.69
$1.64
Volume3.19 million shs
Average Volume574,469 shs
Market Capitalization$43.75 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Reed's (NYSEAMERICAN:REED) Vs. WTER, EMBVF, BTVCF, COCSF, DNAX, and FQVTF

Should you be buying REED stock or one of its competitors? Companies in the industry of "beverages - soft drinks" are considered alternatives and competitors to Reed's, including The Alkaline Water (WTER), Arca Continental (EMBVF), Britvic (BTVCF), Coca-Cola FEMSA (COCSF), DNA Brands (DNAX), and Fevertree Drinks (FQVTF).

Reed's (NYSEAMERICAN:REED) and The Alkaline Water (NYSE:WTER) are both small-cap consumer defensive companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Earnings & Valuation

This table compares Reed's and The Alkaline Water's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Reed'sN/AN/AN/AN/AN/A
The Alkaline WaterN/AN/AN/AN/AN/A

Profitability

This table compares Reed's and The Alkaline Water's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Reed'sN/AN/AN/A
The Alkaline WaterN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Reed's and The Alkaline Water, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Reed's01102.50
The Alkaline Water00203.00

Reed's currently has a consensus target price of $2.50, indicating a potential upside of 262.32%. Given Reed's' higher possible upside, research analysts plainly believe Reed's is more favorable than The Alkaline Water.

Summary

The Alkaline Water beats Reed's on 2 of the 3 factors compared between the two stocks.

Reed's (NYSEAMERICAN:REED) and Arca Continental (OTCMKTS:EMBVF) are both consumer defensive companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Earnings & Valuation

This table compares Reed's and Arca Continental's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Reed'sN/AN/AN/AN/AN/A
Arca ContinentalN/AN/AN/AN/AN/A

Profitability

This table compares Reed's and Arca Continental's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Reed'sN/AN/AN/A
Arca ContinentalN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Reed's and Arca Continental, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Reed's01102.50
Arca Continental01102.50

Reed's currently has a consensus target price of $2.50, indicating a potential upside of 262.32%. Given Reed's' higher possible upside, research analysts plainly believe Reed's is more favorable than Arca Continental.

Summary

Reed's beats Arca Continental on 1 of the 1 factors compared between the two stocks.

Reed's (NYSEAMERICAN:REED) and Britvic (OTCMKTS:BTVCF) are both consumer defensive companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Valuation & Earnings

This table compares Reed's and Britvic's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Reed'sN/AN/AN/AN/AN/A
BritvicN/AN/AN/AN/AN/A

Profitability

This table compares Reed's and Britvic's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Reed'sN/AN/AN/A
BritvicN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Reed's and Britvic, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Reed's01102.50
Britvic01302.75

Reed's presently has a consensus target price of $2.50, suggesting a potential upside of 262.32%. Given Reed's' higher probable upside, analysts clearly believe Reed's is more favorable than Britvic.

Summary

Britvic beats Reed's on 2 of the 3 factors compared between the two stocks.

Coca-Cola FEMSA (OTCMKTS:COCSF) and Reed's (NYSEAMERICAN:REED) are both consumer defensive companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.

Valuation & Earnings

This table compares Coca-Cola FEMSA and Reed's' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Coca-Cola FEMSAN/AN/AN/AN/AN/A
Reed'sN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Coca-Cola FEMSA and Reed's, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Coca-Cola FEMSA0000N/A
Reed's01102.50

Reed's has a consensus price target of $2.50, suggesting a potential upside of 262.32%. Given Reed's' higher probable upside, analysts clearly believe Reed's is more favorable than Coca-Cola FEMSA.

Profitability

This table compares Coca-Cola FEMSA and Reed's' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Coca-Cola FEMSAN/AN/AN/A
Reed'sN/AN/AN/A

Summary

Reed's beats Coca-Cola FEMSA on 2 of the 2 factors compared between the two stocks.

DNA Brands (OTCMKTS:DNAX) and Reed's (NYSEAMERICAN:REED) are both consumer defensive companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

Profitability

This table compares DNA Brands and Reed's' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
DNA BrandsN/AN/AN/A
Reed'sN/AN/AN/A

Earnings and Valuation

This table compares DNA Brands and Reed's' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DNA BrandsN/AN/AN/AN/AN/A
Reed'sN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and price targets for DNA Brands and Reed's, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
DNA Brands0000N/A
Reed's01102.50

Reed's has a consensus target price of $2.50, indicating a potential upside of 262.32%. Given Reed's' higher probable upside, analysts plainly believe Reed's is more favorable than DNA Brands.

Summary

Reed's beats DNA Brands on 2 of the 2 factors compared between the two stocks.

Fevertree Drinks (OTCMKTS:FQVTF) and Reed's (NYSEAMERICAN:REED) are both consumer defensive companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings.

Profitability

This table compares Fevertree Drinks and Reed's' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Fevertree DrinksN/AN/AN/A
Reed'sN/AN/AN/A

Valuation and Earnings

This table compares Fevertree Drinks and Reed's' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fevertree DrinksN/AN/AN/AN/AN/A
Reed'sN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for Fevertree Drinks and Reed's, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Fevertree Drinks32502.20
Reed's01102.50

Reed's has a consensus target price of $2.50, indicating a potential upside of 262.32%. Given Reed's' stronger consensus rating and higher possible upside, analysts clearly believe Reed's is more favorable than Fevertree Drinks.

Summary

Reed's beats Fevertree Drinks on 2 of the 3 factors compared between the two stocks.


Reed's Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
WTER
The Alkaline Water
0.5$1.13+5.3%$72.69 millionN/A0.00High Trading Volume
EMBVF
Arca Continental
0.6$4.80+0.0%$0.00N/A0.00Decrease in Short Interest
BTVCF
Britvic
0.7$10.80+1.4%$0.00N/A0.00Decrease in Short Interest
COCSF
Coca-Cola FEMSA
0.5$4.30+0.0%$0.00N/A0.00Decrease in Short Interest
DNAX
DNA Brands
0.5$0.00+0.0%$0.00N/A0.00
FQVTF
Fevertree Drinks
0.4$33.05+3.5%$0.00N/A0.00Analyst Report
Decrease in Short Interest
Heavy News Reporting
MINE
Minerco
0.5$0.00+0.0%$0.00N/A0.00High Trading Volume
PLSB
The Pulse Beverage
0.5$0.00+0.0%$0.00N/A0.00
UPCHY
Uni-President China
0.5$95.05+0.0%$0.00N/A0.00
UPNT
Uplift Nutrition
0.4$0.05+0.0%$0.00N/A0.00
This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.